(PharmaNewsWire.Com, September 29, 2017 ) The North America Plasma Protein Therapeutics Market is currently valued to be $7.87 Billion market in 2016 held the most dominant share in global market and is estimated to reach $11.1 billion by the end of 2021 with a growth rate of 7.1%. Recent years have witnessed the increased usage of plasma proteins in medical applications. The advancements in technology has made the process for fractionating the protein from plasma more efficient and cost saving and is a huge boost to the market. Reports from suggest that half of the global blood donors are from high income countries which constitutes only 18% of the global population. Rising awareness among individuals regarding the significance of blood donations and government initiatives helped the market to propel the market at a significant rate.
Plasma, which is a protein rich fluid plays a critical role in clotting and providing immunity to diseases. Isolating these proteins from plasma can be helpful for various medical therapies which includes immune deficiencies, autoimmune, bleeding and neurological disorders. By replacing the missing or deficient proteins in plasma, plasma protein therapies can be able to treat life-threatening genetic and chronic diseases.
Rising number of new plasma-derived therapies has increased the demand for the market in the recent years. Rising prevalence of life threatening diseases that involves neurological or immune system and others infectious diseases like Tetanus, Rabies, varicella and Hepatitis A&B are some of the factors enabling the growth of the market. However, there are a few restraints that may prove to be a bottleneck for the growth of the market including stringent regulatory policies, reimbursement issues and manufacturing complexity.
The North America Plasma Protein Therapeutics Market are categorised by product type as Albumin, Coagulation Factors, Immunoglobulins, alpha-1 proteinase inhibitor and others. The market is also analysed by segmenting it based on application as Primary Immunodeficiency Disorder, Secondary Immunodeficiency, Hemophilia, Idiopathic Thrombocytopenic Purpura and others. On the basis of geography, North American market is segmented into US and Canada.
Investment in research & development of the plasma proteins are boosting the prospect of the North America market. The major players in the plasma protein therapeutic market are Baxter, Biotest, CSL Behring, Grifols, China Biologics, Shire Plc., Kedrion, Octapharma and Chengdu Inst.
Scope of the Report
Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
